vitamin K epoxide reductase complex subunit 1
Ultimo aggiornamento 18 Ago 2020
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
L VKORC1 gene provides instructions for making a vitamin K epoxide reductase enzyme. The VKORC1 enzyme is made primarily in the liver. It spans the membrane of a cellular structure called the endoplasmic reticulum, which is involved with protein processing and transport. The VKORC1 enzyme helps turn on (activate) clotting proteins in the pathway that forms blood clots. Specifically, the VKORC1 enzyme converts one form of vitamin K into a different form of vitamin K that assists in activating clotting proteins.
Scelte video per GenesVideo library
Normal function
L VKORC1 gene provides instructions for making a vitamin K epoxide reductase enzyme. The VKORC1 enzyme is made primarily in the liver. It spans the membrane of a cellular structure called the endoplasmic reticulum, which is involved with protein processing and transport. The VKORC1 enzyme helps turn on (activate) clotting proteins in the pathway that forms blood clots. Specifically, the VKORC1 enzyme converts one form of vitamin K into a different form of vitamin K that assists in activating clotting proteins.
Conditions referring to this gene or chromosome
Altri nomi
FLJ00289
vitamin K 1 2,3-epoxide reductase subunit 1
vitamin K epoxide reductase complex, subunit 1
VKOR
Related patient information and medicines

Patient information leaflet
Posso assumere Warfarin e Vitamina K insieme?
Vitamin K can make warfarin less effective, which increases your risk of developing dangerous blood clots or having a stroke. Why this happens Warfarin works by blocking the way your body uses Vitamin K to make blood-clotting factors. Foods high in vitamin K (e.g. spinach, kale, broccoli, Brussels sprouts, asparagus) Vitamin K helps your blood to.

Patient information leaflet
Posso assumere Zenzero e Vitamina C insieme?
Why this happens Ginger and vitamin C work through different pathways in the body and do not interfere with how the other is absorbed, broken down, or used. Ginger is primarily used for its anti-inflammatory and anti-nausea properties, while vitamina C is an antioxidant used for tissue repair and immune function. What you should do It is safe to.

Patient information leaflet
Posso assumere la Vitamina B12 e la Vitamina C insieme?
Perché succede Vitamina C è an antioxidant that can chemically break down Vitamin B12 in the digestive tract, making the B12 inactive and harder for the body to absorb. Our Controllo Interazioni Farmaci helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Disclaimer This information.

Patient information leaflet
Posso prendere Solifenacina e Vitamina C insieme?
There is no known interaction between solifenacin and vitamin C (ascorbic acid). It is generally safe to take these two together. Why this happens Solifenacin is processed by the liver (specifically the CYP3A4 enzyme), while vitamina C is a water-soluble vitamin processed and excreted primarily by the kidneys. They do not share the same metabolic.

Patient information leaflet
Posso assumere acido folico e vitamina C insieme?
In fact, taking them together is generally considered beneficial. Vitamin C can help prevent the breakdown of folic acid in the stomach, potentially making it easier for your body to use. Why this happens Vitamin C (ascorbic acid) acts as an antioxidant that helps stabilise folate (folic acid) nel the digestive tract, protecting it from oxidative.

Patient information leaflet
Posso prendere Ashwagandha e Vitamina C insieme?
Health benefits, uses, and... They do not share the same metabolic pathways in the liver, nor do they interfere with each other's absorption or excretion. Ashwagandha is an adaptogenic herb that works primarily on the body's stress response system (the adrenal glands), while vitamina C è a water-soluble antioxidant. How to take ashwagandha and.
Ulteriori letture e riferimenti
- vitamin K epoxide reductase complex subunit 1; MedlinePlus, National Library of Medicine.
- Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost. 2010 Jan;8(1):95-100. doi: 10.1111/j.1538-7836.2009.03677.x. Epub 2009 Oct 30.
- Flockhart DA, O'Kane D, Williams MS, Watson MS, Flockhart DA, Gage B, Gandolfi R, King R, Lyon E, Nussbaum R, O'Kane D, Schulman K, Veenstra D, Williams MS, Watson MS; ACMG Working Group on Pharmacogenetic Testing of CYP2C9, VKORC1 Alleles for Warfarin Use. Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med. 2008 Feb;10(2):139-50. doi: 10.1097/GIM.0b013e318163c35f.
- Kaye JB, Schultz LE, Steiner HE, Kittles RA, Cavallari LH, Karnes JH. Warfarin Pharmacogenomics in Diverse Populations. Pharmacotherapy. 2017 Sep;37(9):1150-1163. doi: 10.1002/phar.1982. Epub 2017 Sep 6.
- Kurnik D, Qasim H, Sominsky S, Lubetsky A, Markovits N, Li C, Stein CM, Halkin H, Gak E, Loebstein R. Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction. Thromb Haemost. 2012 Oct;108(4):781-8. doi: 10.1160/TH12-03-0151. Epub 2012 Aug 7.
- Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. Identification of the gene for vitamin K epoxide reductase. Nature. 2004 Feb 5;427(6974):541-4. doi: 10.1038/nature02254.
- Lund K, Gaffney D, Spooner R, Etherington AM, Tansey P, Tait RC. Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates. Br J Haematol. 2012 Jul;158(2):256-261. doi: 10.1111/j.1365-2141.2012.09150.x. Epub 2012 May 10.
- Watzka M, Geisen C, Bevans CG, Sittinger K, Spohn G, Rost S, Seifried E, Muller CR, Oldenburg J. Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. J Thromb Haemost. 2011 Jan;9(1):109-18. doi: 10.1111/j.1538-7836.2010.04095.x.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

